Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
12 2020
Historique:
received: 26 01 2020
revised: 10 04 2020
accepted: 28 05 2020
pubmed: 1 7 2020
medline: 6 8 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

To test international society of urological pathology grade group (ISUP GG) concordance rates between multiparametric magnetic resonance imaging (mpMRI) targeted biopsies (TB) vs. standard systematic biopsies (SB) and radical prostatectomy (RP) specimens, in biopsy naïve patients. This retrospective single center study included 80 vs. 500 biopsy naïve patients diagnosed with TB vs. SB and treated with RP between 2015 and 2018. First, we compared ISUP GG concordance rates and the percentages of undetected clinically significant prostate cancer (csPCa: ISUP GG  ≥ 3), between TB vs. SB and RP. Second, multivariable logistic regression models tested predictors of concordance rates before and after 1:3 propensity score (PS) matching. Third, among TB patients, univariable logistic regression models tested variables associated with ISUP GG concordance at RP. Overall, ISUP GG concordance rates were, respectively, 55 vs. 41.4% for TB vs. SB (P = 0.02). However, no differences in concordance rates were observed in patients with biopsy ISUP GG1 (31 vs. 33.9% for TB vs. SB; P = 0.8). Moreover, 15 vs. 18.8% csPCa were missed by TB vs. SB, respectively (P = 0.4). In multivariable logistic regression models, TB were associated with higher concordance rates before (odds ratio [OR]: 1.13; P = 0.04) and after 1:3 PS matching (OR: 1.15; P 0.03), compared to SB. In TB patients, age (OR: 0.98; P = 0.04), maximum cancer core involvement (MCCI; OR: 1.02; P = 0.02) and maximum cancer core length (MCCL; OR: 1.01; P = 0.07) were associated with ISUP GG concordance. Moreover, a trend for lower concordance rates was observed with higher PSA-D (OR: 0.77; P = 0.1). Finally, intermediate lesion location at mpMRI was associated with lowest concordance rates (44%). In biopsy naïve patients treated with RP, TB achieved higher rates of ISUP GG concordance, but same percentages of csPCa missed, compared to SB. Moreover, only patients with ISUP GG ≥2, but not patients with ISUP GG1, exhibited higher concordance rates. Finally, age, MCCI, MCCL, PSA-D, and lesion location were associated with concordance between TB and RP.

Identifiants

pubmed: 32600928
pii: S1078-1439(20)30260-X
doi: 10.1016/j.urolonc.2020.05.027
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

929.e11-929.e19

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Stefano Luzzago (S)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Universita degli Studi di Milano, Milan, Italy. Electronic address: stefanoluzzago@gmail.com.

Giuseppe Petralia (G)

Universita degli Studi di Milano, Department of Oncology and Hematology-Oncology, Milan, Italy; Precision Imaging and Research Unit- Department of Department of Medical Imaging and Radiation Sciences, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Duilia Maresca (D)

Universita degli Studi di Milano, Milan, Italy; Department of Radiology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Ilaria Sabatini (I)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Universita degli Studi di Milano, Milan, Italy.

Giovanni Cordima (G)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Antonio Brescia (A)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Fabrizio Verweij (F)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Giulia Garelli (G)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Universita degli Studi di Milano, Milan, Italy.

Francesco A Mistretta (FA)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Universita degli Studi di Milano, Milan, Italy.

Antonio Cioffi (A)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Paola Pricolo (P)

Department of Radiology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Sarah Alessi (S)

Department of Radiology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Matteo Ferro (M)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Deliu-Victor Matei (DV)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Giuseppe Renne (G)

Department of Pathology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Ottavio de Cobelli (O)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy; Universita degli Studi di Milano, Department of Oncology and Hematology-Oncology, Milan, Italy.

Gennaro Musi (G)

Department of Urology, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH